Symbols

QUCY

Mainz Biomed·NASDAQ

--(--)

7.17 / 10

Outperform

Analyst coverage is absent, but fund‑flow sentiment is strong (7.17/10). Small and medium investors show positive inflows, while large blocks are net sellers. Overall inflow ratio is 0.42, indicating modest buying pressure despite a negative trend.

Fund Flow Rating

What is the analyst consensus for QUCY?

QUCY holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.17/10 (Outperform).